FDA: Thyroid Medications Recalled Due to Inconsistent Potency

Lab tests confirmed Sichuan Friendly API had inconsistent levels of levothyroxine and liothyronine
Lab tests confirmed Sichuan Friendly API had inconsistent levels of levothyroxine and liothyronine

Westminster Pharmaceuticals announced a recall of all lots of Levothyroxine and Liothyronine (Thyroid Tablets) 15mg, 30mg, 60mg, 90mg, 120mg as the product was manufactured using active pharmaceutical ingredients (API) from a company that was found to have deviated from the Food and Drug Administration (FDA)'s Good Manufacturing Practices.

FDA laboratory tests confirmed Sichuan Friendly Pharmaceutical's API had inconsistent levels of both levothyroxine and liothyronine, prompting the recall of all product from Westminster Pharmaceuticals. A list of affected products can be found here. In a press statement, Westminster said that they have yet to receive any reports of adverse events related to this recall.

Related Articles

Levothyroxine and liothyronine are used in the treatment of hypothyroidism. The FDA is advising patients affected by this recall to speak to their healthcare providers regarding alternative treatment.

For more information visit FDA.gov.